基因毒性測試市場：按類型、按產品、按最終用戶、按地區

預計2024年全球基因毒性測試市場規模為14.1億美元，預計2031年將達33.3億美元，2024年至2031年複合年成長率為13.1%。

圖：2024 年按地區分類的基因毒性測試市場佔有率(%)

全球基因毒性測試市場在歷史期間（2019-2028）呈現穩定成長，預計在預測期間（2024-2031）將出現正成長。這主要歸因於化學品和消費品安全評估意識的增強。癌症相關疾病的增加、嚴格的法規（尤其是製藥業）以及高性能技術的快速進步等因素是基因毒性測試行業的高影響力促進因素。然而，與評估基因毒性終點相關的複雜性仍然在一定程度上限制了市場的成長。整體而言，全球基因毒性測試市場預計 2024-2031 年複合年成長率為 13.1%。

市場動態：

由於全球癌症發生率上升，製藥和生物技術領域對安全化學品/藥物開發的需求不斷成長，推動了全球基因毒性測試市場的發展。據世界衛生組織稱，到2040年，癌症患者人數預計將達到2,750萬，癌症死亡人數將達1,630萬。此外，美國食品藥物管理局等監管機構強制進行早期安全評估的嚴格指導方針正在推動其採用。然而，由於臨床前評估中解讀遺傳毒性終點的複雜性以及傳統測試方法的技術限制，市場成長可能會受到挑戰。領先的市場開拓公司正在投資研發，以開發高效能篩檢分析和服務來解決這些問題。

本研究的主要特點

該報告對全球基因毒性測試市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。它。

它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。

它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球基因毒性測試市場的主要企業。

本研究涵蓋的主要企業包括 Charles River、Thermo Fisher Scientific、F. Hoffmann-La Roche Ltd、Jubilant Life Sciences、Cyprotex、Merck KGaA、Gentronix Limited、BioReliance、Creative Biolabs 等。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於全球基因毒性測試市場分析的各種策略矩陣，將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

• 研究目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• 一致的機會地圖 (COM)

第3章市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管場景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章全球基因毒性測試市場-冠狀病毒（COVID-19）大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第5章 2019-2031 年全球基因毒性測試市場（按類型）（十億美元）

• 介紹
• 體外
• 體內

第6章 全球基因毒性測試市場（按產品），2019-2031（十億美元）

• 介紹
• 試劑
• 消耗品
• 化驗
• 服務

第 7 章 全球基因毒性測試市場，按最終用戶分類，2019-2031 年（十億美元）

• 介紹
• 合約研究組織
• 製藥公司
• 化學公司
• 其他

第8章全球基因毒性測試市場，按地區，2019-2031（十億美元）

• 介紹
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東

第9章 競爭格局

• 公司簡介
  • Thermo Fisher Scientific, Inc.
  • WuXi AppTec
  • Charles River Laboratories International
  • Laboratory Corp of America Holdings
  • Eurofins Scientific
  • Jubilant Life Sciences Limited
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv Inc.
  • Creative Bioarray
  • MB Research Laboratories
  • Molecular Toxicology, Inc.
  • Toxys
  • GeneTox Worldwide, Inc.

第10章分析師建議

• 上升和下降
• 綜合機會圖

第11章 參考文獻與調查方法

• 參考
• 調查方法

The global genetic toxicology testing market is estimated to be valued at USD 1.41 Bn in 2024 and is expected to reach USD 3.33 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.1% from 2024 to 2031.

Figure. Genetic Toxicology Testing Market Share (%), By Region 2024

The global genetic toxicology testing market witnessed a steady growth during the historic period (2019-2028) and is projected to see positive gains in the forecast period (2024-2031). This can be primarily attributed to rising awareness about the safety assessment of chemicals and consumer products. Factors such as increasing instances of cancer related diseases, stringent regulations especially in pharmaceutical industry, and rapid advancements of high throughput technologies will serve as high impact rendering drivers for the genetic toxicology testing industry. However, complexities associated with the assessment of genotoxicity endpoints continue to restrict the market growth to a certain extent. Overall, the global genetic toxicology testing market is poised to exhibit a promising 13.1% CAGR during 2024-2031.

Market Dynamics:

The global genetic toxicology testing market is driven by rising incidences of cancer worldwide translating to the increasing demand from the pharmaceutical and biotechnology sectors for safe chemical/drug development. As per WHO, the cancer burden is projected to reach 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. Furthermore, stringent guidelines mandating early safety assessment by regulatory bodies like USFDA, boosts adoption. However, market growth can be challenged due to complexities in deciphering genotoxicity endpoints during preclinical evaluation and technical limitations of few traditional testing methods. Key market players are investing in R&D to develop high throughput screening assays and services to address such issues opening opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global genetic toxicology testing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global Genetic Toxicology Testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Charles River, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Jubilant Life Sciences, Cyprotex, Merck KGaA, Gentronix Limited, BioReliance, Creative Biolabs

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global genetic toxicology testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genetic toxicology testing market

Detailed Segmentation-

• By Type
  • In Vitro
  • In Vivo
• By Product
  • Reagents
  • Consumables
  • Assays
  • Services
• By End User
  • Contract Research Organizations
  • Pharmaceutical Companies
  • Chemical Companies
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific, Inc.
  • WuXi AppTec
  • Charles River Laboratories International
  • Laboratory Corp of America Holdings
  • Eurofins Scientific
  • Jubilant Life Sciences Limited
  • Syngene International Limited
  • Gentronix Ltd.
  • Inotiv Inc.
  • Creative Bioarray
  • MB Research Laboratories
  • Molecular Toxicology, Inc.
  • Toxys
  • GeneTox Worldwide, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Product
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Genetic Toxicology Testing Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Genetic Toxicology Testing Market, By Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• In Vitro
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• In Vivo
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Genetic Toxicology Testing Market, By Product, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Reagents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Consumables
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Assays
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Genetic Toxicology Testing Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Contract Research Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Chemical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Genetic Toxicology Testing Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • WuXi AppTec
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Charles River Laboratories International
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Laboratory Corp of America Holdings
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eurofins Scientific
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Jubilant Life Sciences Limited
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Syngene International Limited
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Gentronix Ltd.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Inotiv Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Creative Bioarray
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MB Research Laboratories
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Molecular Toxicology, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Toxys
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GeneTox Worldwide, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact